Wells Fargo
LPCN icon

Wells Fargo’s Lipocine LPCN Stock Holding History

Wells Fargo’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Buy
+2,706
New +$23.6K ﹤0.01% 5742
2024
Q2 		– Sell
-42
Closed -$218 – 7223
2024
Q1 		$218 Buy
42
+1
+2% +$4 ﹤0.01% 6477
2023
Q4 		$114 Buy
41
+2
+5% +$5 ﹤0.01% 6733
2023
Q3 		$116 Buy
39
+2
+5% +$8 ﹤0.01% 6731
2023
Q2 		$186 Buy
37
+1
+3% +$5 ﹤0.01% 6722
2023
Q1 		$195 Buy
36
+1
+3% +$8 ﹤0.01% 6780
2022
Q4 		$240 Hold
35
– – ﹤0.01% 6570
2022
Q3 		$0 Sell
35
-176
-83% -$1.97K ﹤0.01% 7060
2022
Q2 		$2K Buy
211
+3
+1% +$47 ﹤0.01% 6340
2022
Q1 		$5K Sell
208
-34
-14% -$711 ﹤0.01% 6473
2021
Q4 		$5K Hold
242
– – ﹤0.01% 6705
2021
Q3 		$5K Buy
242
+175
+261% +$3.86K ﹤0.01% 6374
2021
Q2 		$2K Buy
67
+1
+2% +$24 ﹤0.01% 6543
2021
Q1 		$2K Buy
66
+41
+164% +$1.18K ﹤0.01% 6639
2020
Q4 		$1K Buy
25
+1
+4% +$24 ﹤0.01% 6358
2020
Q3 		$1K Buy
24
+12
+100% +$319 ﹤0.01% 6217
2020
Q2 		$0 Hold
12
– – ﹤0.01% 6591
2020
Q1 		$0 Buy
+12
New +$95 ﹤0.01% 6540
2017
Q2 		– Sell
-1,613
Closed -$107K – 6348
2017
Q1 		$107K Hold
1,613
– – ﹤0.01% 5166
2016
Q4 		$101K Hold
1,613
– – ﹤0.01% 5144
2016
Q3 		$122K Buy
+1,613
New +$99.9K ﹤0.01% 4795
2016
Q2 		– Sell
-6
Closed -$1K – 6226
2016
Q1 		$1K Sell
6
-348
-98% -$59.4K ﹤0.01% 6100
2015
Q4 		$78K Buy
+354
New +$74.3K ﹤0.01% 5084

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Wells Fargo's LPCN Position: Q1 2026 in Review

Wells Fargo opened a new position in Lipocine (LPCN) in Q1 2026: 2,706 shares worth $21.6K. The stake represents ﹤0.01% of the portfolio and ranks #5742 among its holdings. This is a return to the name: Wells Fargo previously reported a position in LPCN as recently as Q1 2024.

Wells Fargo first reported a position in LPCN in Q4 2015 and has held it in 23 quarters since. The position peaked at $122K in Q3 2016. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Wells Fargo held 2,706 shares of Lipocine worth $21.6K as of Q1 2026.
  • Lipocine was a new Wells Fargo position in Q1 2026.
  • Lipocine made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5742 holding.
  • Wells Fargo first reported a position in Lipocine in Q4 2015 and has held it in 23 quarters since.
  • Wells Fargo's Lipocine position peaked at $122K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.